Table 2.
Predictorsa of the change in SRH over time [β estimate (SE)] by incident disease status: the ARIC Study (1987–2006)
| Disease-free (n = 11,188) | Cardiac revascularisation procedure (n = 1,340) | Myocardial infarction (n = 1,071) | Lung cancer (n = 433) | Stroke (n = 809) | Heart failure (n = 1,592) | |
|---|---|---|---|---|---|---|
| Intercept | 87.7 (0.8)* | 84.8 (2.2)* | 78.5 (2.9)* | 79.7 (4.6)* | 81.3 (3.4)* | 71.2 (2.5)* |
| Age, centred at 65 | −0.5 (0.04)* | −0.3 (0.1)* | −0.6 (0.1)* | −0.3 (0.2) | −0.9 (0.1)* | −0.3 (0.1)* |
| Age2 | −0.03 (0.002)* | −0.02 (0.004)* | −0.03 (0.005)* | −0.02 (0.01)* | −0.03 (0.01)* | −0.03 (0.005)* |
| nINC (vs. High) | ||||||
| Low | −2.3 (0.8)* | −5.2 (1.7)* | −5.0 (2.3)* | 2.0 (5.0) | 1.8 (2.1) | −0.04 (1.6) |
| Medium | −1.2 (0.6)* | −0.9 (1.3) | 1.2 (1.9) | 6.2 (3.8) | −0.6 (1.9) | 0.5 (1.4) |
| Female (vs. Male) | −1.0 (0.3)* | −3.7 (1.0)* | −1.9 (1.2) | −0.6 (1.7) | 1.7 (1.3) | 0.01 (1.0) |
| Race/study community (vs. White/MD) | ||||||
| Black/NC | −6.5 (0.9)* | −1.3 (2.8) | −7.4 (3.5)* | −6.1 (5.3) | −9.1 (3.7)* | −8.0 (2.8)* |
| Black/MS | −8.7 (0.6)* | −3.7 (1.8)* | −6.1 (2.0)* | −5.5 (2.9) | −10.7 (2.2)* | −7.5 (1.6)* |
| White/NC | −0.8 (0.4) | −0.6 (1.1) | 0.1 (1.6) | 1.9 (2.2) | −2.1 (2.1) | −3.6 (1.4)* |
| White/MN | 0.1 (0.5) | 2.1 (1.3) | 4.6 (1.8)* | 1.6 (2.6) | 2.6 (2.2) | 2.4 (1.6) |
| Hypertensive | −4.9 (0.3)* | −4.4 (0.9)* | −5.6 (1.2)* | −2.4 (1.8) | −7.9 (1.4)* | −4.2 (1.0)* |
| BMI (vs. Normal) | ||||||
| Obese | −4.8 (0.4)* | −6.8 (1.2)* | −5.8 (1.5)* | −5.4 (2.1)* | −7.1 (1.7)* | −2.8 (1.3)* |
| Overweight | −0.7 (0.3)* | −2.8 (1.1)* | −1.3 (1.4) | −1.1 (1.9) | −3.6 (1.6)* | 0.9 (1.3) |
| Current smoker | −4.0 (0.4)* | −3.8 (1.0)* | −4.2 (1.2)* | −4.7 (1.8)* | −7.8 (1.4)* | −3.8 (1.0)* |
| Current drinker | 1.6 (0.3)* | 3.6 (0.9)* | 3.4 (1.2)* | 0.9 (1.8) | 2.5 (1.4) | 2.8 (1.0)* |
| Educational attainment (vs. Greater than HS) | ||||||
| Less than HS | −9.5 (1.0)* | −9.7 (1.3)* | −10.3 (1.5)* | −11.5 (5.2)* | −12.9 (1.7)* | −9.5 (1.3)* |
| HS or equivalent | −3.2 (0.5)* | −3.4 (1.0)* | −5.0 (1.3)* | 4.7 (3.2) | −6.0 (1.5)* | −3.9 (1.2)* |
| Contact year | −0.3 (0.04)* | −0.2 (0.1) | 0.1 (0.1) | −0.6 (0.2)* | 0.1 (0.2) | −0.4 (0.1)* |
| Disease status | −1.7 (0.3)* | −14.9 (1.1)* | −19.5 (1.2)* | −44.7 (2.4)* | −4.8 (1.3)* | −26.3 (1.2)* |
| 1987−92 (vs. 2000−06) | −0.6 (0.4) | 0.9 (1.1) | 1.4 (1.5) | −1.3 (2.1) | 3.0 (1.3)* | 5.0 (1.0)* |
| 1993−99 (vs. 2000−06) | −0.01 (0.2) | 0.04 (0.7) | −0.03 (1.0) | −0.8 (1.3) | 2.3 (0.7)* | 3.2 (0.6)* |
| Age, centred at 65*1987−92 | −0.1 (0.05)* | NS | NS | NS | 0.03 (0.2) | NS |
| Age, centred at 65*1993−99 | 0.05 (0.03) | NS | NS | NS | 0.3 (0.1)* | NS |
| Low nINC*Less than HS | −3.9 (1.2)* | NS | NS | 1.9 (6.8) | NS | NS |
| Low nINC*HS or equivalent | −2.7 (0.8)* | NS | NS | −12.4 (5.6)* | NS | NS |
| Medium nINC*Less than HS | −1.5 (1.2) | NS | NS | −4.6 (6.3) | NS | NS |
| Medium nINC*HS or equivalent | −0.3 (0.8) | NS | NS | −8.2 (4.6) | NS | NS |
| Low nINC*1987−92 | 2.0 (0.4)* | 1.8 (1.3) | 3.3 (1.6)* | NS | NS | NS |
| Low nINC*1993−99 | 0.6 (0.3) | −0.3 (1.0) | 2.1 (1.2) | NS | NS | NS |
| Medium nINC*1987−92 | 0.4 (0.4) | 0.5 (1.1) | −0.6 (1.6) | NS | NS | NS |
| Medium nINC*1993−99 | 0.3 (0.3) | 1.5 (0.8)* | 1.0 (1.2) | NS | NS | NS |
| Contact year*Disease status | 0.2 (0.03)* | 0.4 (0.1)* | −0.6 (0.1)* | 0.6 (0.2)* | 0.2 (0.1) | 0.8 (0.1)* |
aSignificant predictors (P < 0.05) are indicated with an (*); NS, interaction not significant for this model.